EHRA 2023 Symposium – Hybrid Ablation: AF and Beyond
At 15:45 CET (9:45 ET) on 16 April at EHRA 2023 in Barcelona, ES, Radcliffe Education is hosting a CME-accredited symposium entitled 'Hybrid Ablation: AF and Beyond'.
Under the expert moderation of Prof Harry Crijns (Maastricht, NL), a leading international faculty comprising Prof Carlo de Asmundis (Brussels, BE), Prof Mark La Meir (Brussels, BE) and Dr Ashley Nisbet (Bristol, UK) will examine which arrhythmias could benefit from a hybrid approach, review the practical implementation of hybrid ablation in IST, and consider learnings from persistent and long-standing AF.
With the applications of hybrid ablation stretching beyond the traditional AF core, this insightful session will be both evidence-based and practical with case studies demonstrating real-world applications. The session will also consider the knowledge and team composition requirements to enhance effectiveness when administering the hybrid procedure for optimal long-term patient outcomes.
This symposium is supported by an unrestricted educational grant from AtriCure Inc.
- Identify arrhythmias other than atrial fibrillation that may benefit from hybrid ablation
- Summarise the existing evidence base for hybrid ablation in IST, POTS and Brugada Syndrome
- Identify patients who may benefit from a hybrid ablation approach
- Recall existing RCT and real-world evidence supporting the use of hybrid ablation in AF
Hybrid Ablation: AF and Beyond – Programme
15:45, Sunday 16 April, Barcelona, ES (45 minutes)
Chair’s welcome – Harry Crijns, Maastricht, NL
Which arrhythmias could benefit from a hybrid approach? – Carlo De Asmundis, Brussels, BE
Hybrid ablation in IST: A case study – Mark La Meir, Brussels, BE
What can we learn from persistent and long-standing persistent AF? – Ashley Nisbet, Bristol, UK
Panel discussion and audience Q&A – All, moderated by Harry Crijns, Maastricht, NL
Close – Harry Crijns, Maastricht, NL
Hall 8, Fira Gran Via North Entrance Carrer del Foc